are routinely used in anaesthesia for the humidification and warming of inspired gases. The use of the Laryngeal Mask Airway (LMA) is widespread, and many anaesthetists choose to leave it in situ until the patient regains consciousness. In this study, we have investigated the effectiveness of an HME as a means of administering supplemental oxygen via LMA in the immediate postoperative period. Oxygen was administered at varying flow rates via the gas sampling port of the HME and the oxygen delivery recorded, using end-tidal oxygraphy as a measure of alveolar PO 2 . At an oxygen flow rate of 4 l.min -1 , the HME provided a mean end-tidal oxygen concentration of 36.2% (±6.2), which compares favourably to other previously described devices. The HME thus represents a convenient, effective and economical means of oxygen supplementation via the LMA.
The Laryngeal Mask Airway (LMA) is used extensively in anaesthetic practice and whilst some anaesthetists choose to remove it prior to leaving theatre, many leave it in situ until the patient regains consciousness in the recovery room. Oxygen is used routinely in the immediate postoperative period to prevent hypoxaemia. However, oxygen supplementation is not without hazard. Barotrauma has been reported with an endotracheal tube 1 , but this is very unlikely with the LMA since leakage will occur around the cuff once airway pressures reach 20 to 25 cmH 2 O 2 . Nevertheless, it may lead to gastric distension and its sequelae, including regurgitation and vomiting.
A number of methods of administering supplementary oxygen via the LMA have been described. These include various T-piece systems 3-5 , a modified Bain coaxial circuit 6 , a paediatric breathing system 7 and recently the "T-bag" 8 . However, these techniques require adaptations of existing equipment or the purchase of specific devices. The possible use of a heat-and-moisture exchanger (HME) for oxygen supplementation via the LMA, delivering oxygen through the gas sampling port, was recently reported in human volunteers, suggesting that the HME may prove to be more efficient than other devices 9 . In addition, we had noticed anaesthetists in our department using the HME in this way. Since HMEs are widely used during general anaesthesia for warming and humidifying dry anaesthetic gases, their "recycling" in this way is both convenient and cost effective. In this clinical study we have investigated the delivery of supplementary oxygen through the LMA via the Hydro-Therm ® HME (Intersurgical Ltd, U.K.).
To determine oxygen delivery by our system we used end-tidal oxygraphy. This has been shown to provide a close correlation between the measured end-tidal oxygen concentration (F É O 2 ) and the calculated alveolar oxygen concentration from the alveolar gas equation 10, 11 . The inspired oxygen concentration (F I O 2 ) delivered will vary significantly depending on respiratory pattern, as the HME as studied, with a reservoir of only 17 ml, will behave as a variable performance device. Therefore, F É O 2 may provide a more accurate guide to pulmonary oxygen reserves than F I O 2 .
MATERIALS AND METHODS
After obtaining local ethics committee approval, we studied 46 adult patients undergoing general anaesthesia in whom a laryngeal mask airway was used for airway control. Informed consent was not obtained from our subjects, as our local ethics committee deemed this unnecessary. Age, sex, weight and ASA grade were recorded. Patients in ASA classes of 4 or 5 were excluded from the study.
The Capnomac Ultima ® gas analyser (Datex Instrumentarium Corporation, Helsinki, Finland) was used for determination of oxygen concentration following calibration as per the manufacturer's instructions. On the arrival of a subject in the recovery room, the gas sampling line of the Capnomac Ultima was passed through the centre of the HME used intra-operatively via a modified central venous catheter tunnelling device. The sampling line was then positioned so as to sit just inside the laryngeal opening of the LMA. A length of oxygen tubing connected to a rotameter on the wall oxygen supply was then attached to the gas sampling port of the HME, as shown in Figure 1 . Throughout the period of investigation, each subject was monitored continuously with pulse oximetry.
Readings of the F I O 2 and F É O 2 were taken every 20 seconds and although end-tidal carbon dioxide (CO 2 ) concentrations were also displayed on the Capnomac Ultima , these were not recorded as it was felt that the chances of rebreathing occurring were minimal. The initial oxygen flow rate was 2 l.min -1 . This was subsequently increased to 4 l.min -1 once steady state had been reached. A further series of measurements were obtained with an oxygen flow of 6 l.min -1 . If the patient regained consciousness before completion of all the readings then the patient was excluded from the study.
Descriptive statistics were obtained using Microsoft Excel 97 (Microsoft Corporation, Redmond, Washington, U.S.A.), whilst SAS version 6.12 statistics software (SAS Institute Inc., Cary, North Carolina, U.S.A.) was used to compare end-tidal oxygen concentrations measured at each flow rate.
RESULTS
Forty-six patients were entered into the study. Six failed to complete the study protocol and were therefore excluded. The mean age of the 40 subjects that completed the study was 54.5 years (range 16 to 83 years), 19 were male and 21 were female. Twenty patients were ASA grade 1, 17 were ASA 2 and the remaining three were ASA 3.
The results of the study are presented in Table 1 . The inspired and end-tidal oxygen concentrations measured at the three oxygen flow rates, plus the calculated standard deviations, are shown. There were no adverse events, including hypoxaemia (oxygen saturations <92%) at any stage in the study. Statistical analysis comparing the F É O 2 at 2 versus 4 l.min -1 , and 4 versus 6 l.min -1 demonstrates a highly significant difference (P<0.01).
DISCUSSION
This study demonstrates that an HME can be used effectively to provide supplemental oxygen through the LMA in the immediate postoperative period, and is consistent with the volunteer study of Dashfield et al 10 . It is both simple and convenient, and since HMEs are in widespread use in general anaesthesia, it is also cost effective, avoiding the purchase of additional equipment to administer supplemental oxygen. The HME possesses many of the ideal properties for an oxygen enrichment device as suggested by Martin and 9 . It is cheap, disposable, small, lightweight, valveless with minimal resistance to breathing and provides reliable oxygenation at an oxygen flow of 4 l.min -1 . Although the HME does not directly permit monitoring of respiration and/or assisted ventilation, these can be achieved by the attachment of a Mapleson C breathing circuit.
The HME performs as well as, if not better than, several other previously described devices. Our measured values for F É O 2 , obtained using end-tidal oxygraphy, are comparable to calculated values for F É O 2 for the Portex Thermovent O 2 3 and the Bain system 5 . In such variable performance devices, the F É O 2 may provide a closer representation of pulmonary oxygen reserves than the F I O 2 , since the F I O 2 will vary considerably during inspiration, with high concentrations at the beginning of inspiration, compared to values approaching room air towards the end of inspiration. In our study adequate pulmonary oxygen reserves are maintained with an oxygen flow of only 4 l.min -1 , this delivering a mean F É O 2 of 36.2%. At such a flow rate it is most unlikely that there was any significant rebreathing of CO 2 , since the volume of the Hydro-Therm ® HME is only 17 ml. This assertion is further supported by Lewis et al who failed to demonstrate CO 2 rebreathing with a modified Bain circuit with a reservoir of 120 ml 6 .
We also recorded the mean F I O 2 as displayed by our measuring equipment to allow a more direct comparison with other previously described devices. At an oxygen flow of 4 l.min -1 , the HME delivered an F I O 2 of 51.7%, compared with 41.3% for the Portex Thermovent O 2 3 and 43% for a modified Bain system 5 , although when compared to the T-bag at a rate of 6 l.min -1 , the latter appears to perform better 9 . The HME also outperforms a 28% and 35% Venturi 4 , but, being a fixed performance device, the Venturi will deliver a set F I O 2 regardless of the oxygen flow. As with other variable performance devices, increas-ing the oxygen flow rate through the HME increased the F I O 2 delivered.
In conclusion, the use of an HME as a means of delivering supplemental oxygen is effective and convenient, and it possesses many of the properties of an ideal oxygen enrichment device. We recommend an oxygen flow of 4 l.min -1 to maintain alveolar oxygenation in the immediate postoperative period.
